Cognitive Flexibility Training Improves Extinction Retention Memory and Enhances Cortical Dopamine With and Without Traumatic Stress Exposure.

PTSD cognitive flexibility dopamine norepinephrine single prolonged stress trauma

Journal

Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952

Informations de publication

Date de publication:
2019
Historique:
received: 04 11 2018
accepted: 30 01 2019
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 19 3 2019
Statut: epublish

Résumé

Stress exposure can cause lasting changes in cognition, but certain individual traits, such as cognitive flexibility, have been shown to reduce the degree, duration, or severity of cognitive changes following stress. Both stress and cognitive flexibility training affect decision making by modulating monoamine signaling. Here, we test the role cognitive flexibility training, and high vs. low cognitive flexibility at the individual level, in attenuating stress-induced changes in memory and monoamine levels using the single prolonged stress (SPS) rodent model of traumatic stress in male Sprague-Dawley rats. Exposure to SPS can heighten fear responses to conditioned cues (i.e., freezing) after a fear association has been extinguished, referred to as a deficit in extinction retention. This deficit is thought to reflect an impairment in context processing that is characteristic of posttraumatic stress disorder (PTSD). During a cognitive flexibility training we assessed individual variability in cognitive skills and conditioned rats to discriminately use cues in their environment. We found that cognitive flexibility training, alone or followed by SPS exposure, accelerated extinction learning and decreased fear responses over time during extinction retention testing, compared with rats not given cognitive flexibility training. These findings suggest that cognitive flexibility training may improve context processing in individuals with and without traumatic stress exposure. Individual performance during the reversal phase of the cognitive flexibility training predicted subsequent context processing; individuals with high reversal performance exhibited a faster decrease in freezing responses during extinction retention testing. Thus, high reversal performance predicted enhanced retention of extinction learning over time and suggests that cognitive flexibility training may be a strategy to promote context processing. In a brain region vital for maintaining cognitive flexibility and fear suppression, the prelimbic cortex (PLC), cognitive flexibility training also lastingly enhanced dopamine (DA) and norepinephrine (NE) levels, in animals with and without traumatic stress exposure. In contrast, cognitive flexibility training prior to traumatic stress exposure decreased levels of DA and its metabolites in the striatum, a region mediating reflexive decision making. Overall, our results suggest that cognitive flexibility training can provide lasting benefits by enhancing extinction retention, a hallmark cognitive effect of trauma, and prelimbic DA, which can maintain flexibility across changing contexts.

Identifiants

pubmed: 30881293
doi: 10.3389/fnbeh.2019.00024
pmc: PMC6406056
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24

Subventions

Organisme : RRD VA
ID : I01 RX002252
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042057
Pays : United States

Références

Anim Behav. 1999 Feb;57(2):393-407
pubmed: 10049480
Eur J Pharmacol. 1999 Feb 19;367(2-3):197-206
pubmed: 10078993
Neuroreport. 1999 Sep 9;10(13):2763-7
pubmed: 10511436
J Neurosci. 2000 Jun 1;20(11):4320-4
pubmed: 10818167
J Neural Transm (Vienna). 2000;107(12):1413-26
pubmed: 11458994
J Neurosci. 2001 Aug 1;21(15):RC157
pubmed: 11459878
Pol J Pharmacol. 2001 Nov-Dec;53(6):587-96
pubmed: 11985332
Neuropsychopharmacology. 2003 Mar;28(3):490-8
pubmed: 12629528
J Atten Disord. 2002;6 Suppl 1:S31-43
pubmed: 12685517
Psychopharmacology (Berl). 2004 Mar;172(2):225-9
pubmed: 14586539
Neuroscience. 2004;129(2):297-308
pubmed: 15501588
Prog Neurobiol. 2004 Dec;74(5):301-20
pubmed: 15582224
Nat Neurosci. 2005 Jun;8(6):805-12
pubmed: 15908948
Psychopharmacology (Berl). 2005 Dec;183(2):171-80
pubmed: 16163517
Neuroscience. 2006 Feb;137(3):1039-49
pubmed: 16298081
Neuron. 2006 Feb 16;49(4):603-15
pubmed: 16476668
Am J Psychiatry. 2006 Jul;163(7):1282-4
pubmed: 16816237
Biol Psychiatry. 2006 Aug 15;60(4):376-82
pubmed: 16919525
Cereb Cortex. 2007 Jun;17(6):1444-53
pubmed: 16920882
J Neurosci. 2006 Aug 23;26(34):8810-8
pubmed: 16928870
Biol Psychiatry. 2007 Sep 1;62(5):446-54
pubmed: 17217927
J Am Acad Child Adolesc Psychiatry. 2007 Mar;46(3):341-55
pubmed: 17314720
J Cogn Neurosci. 2007 Mar;19(3):468-78
pubmed: 17335395
J Physiol. 2007 Oct 15;584(Pt 2):437-50
pubmed: 17702809
J Comp Psychol. 2007 Nov;121(4):372-9
pubmed: 18085920
J Psychiatr Res. 2008 Jun;42(7):515-20
pubmed: 18313695
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):16027-32
pubmed: 18832466
Conscious Cogn. 2009 Mar;18(1):176-86
pubmed: 19181542
J Clin Psychol Med Settings. 2009 Jun;16(2):186-93
pubmed: 19330430
J Neurosci. 2009 Apr 15;29(15):4690-6
pubmed: 19369539
Science. 2009 Jul 31;325(5940):621-5
pubmed: 19644122
J Neurosci. 2009 Sep 9;29(36):11089-97
pubmed: 19741115
Biol Psychiatry. 2009 Dec 15;66(12):1075-82
pubmed: 19748076
Depress Anxiety. 2009;26(12):1110-7
pubmed: 19918929
Behav Pharmacol. 2010 Feb;21(1):39-46
pubmed: 19949320
Curr Opin Neurobiol. 2010 Apr;20(2):199-204
pubmed: 20167474
Behav Neurosci. 2010 Apr;124(2):204-10
pubmed: 20364880
Neurosci Lett. 2010 Aug 9;480(1):16-20
pubmed: 20546834
Biol Psychiatry. 2010 Dec 1;68(11):1055-60
pubmed: 20926066
Neuropsychopharmacology. 2011 Feb;36(3):627-37
pubmed: 21048702
Psychiatry (Edgmont). 2005 Apr;2(4):14-25
pubmed: 21179648
Behav Brain Res. 2011 Jun 20;220(1):106-11
pubmed: 21277333
Biol Psychiatry. 2011 Jun 1;69(11):1109-16
pubmed: 21392734
Cogn Emot. 2011 Feb;25(2):380-8
pubmed: 21432680
Learn Mem. 2012 Jan 12;19(2):43-9
pubmed: 22240323
PLoS One. 2012;7(1):e28331
pubmed: 22253689
Stud Health Technol Inform. 2012;173:379-85
pubmed: 22357022
Biol Psychiatry. 2012 Jul 15;72(2):157-63
pubmed: 22534456
Intensive Care Med. 2012 Sep;38(9):1445-51
pubmed: 22618093
Curr Dir Psychol Sci. 2012 Feb;21(1):8-14
pubmed: 22773897
J Adolesc Health. 2012 Aug;51(2 Suppl):S17-22
pubmed: 22794528
Eur J Pharmacol. 2013 Mar 5;703(1-3):62-6
pubmed: 23422875
Int J Eat Disord. 2013 Jul;46(5):492-5
pubmed: 23658098
Aggress Behav. 2013 Sep-Oct;39(5):355-69
pubmed: 23677518
Pharmacol Biochem Behav. 2014 Aug;123:45-54
pubmed: 23978501
Behav Brain Res. 2013 Nov 1;256:591-7
pubmed: 24036168
Int J Eat Disord. 2014 Jan;47(1):24-31
pubmed: 24166941
Front Neurosci. 2013 Nov 05;7:201
pubmed: 24204329
Eur J Neurosci. 2014 Apr;39(8):1281-93
pubmed: 24494713
Psychopharmacology (Berl). 2014 Oct;231(20):3941-52
pubmed: 24647923
Neurobiol Stress. 2015 Jan 1;1:89-99
pubmed: 25436222
ACS Chem Neurosci. 2015 Mar 18;6(3):485-93
pubmed: 25581551
Neurobiol Stress. 2015 Jan;1:60-65
pubmed: 25729759
Behav Brain Res. 2015 Jun 1;286:256-64
pubmed: 25746511
J Nerv Ment Dis. 2015 Apr;203(4):287-93
pubmed: 25784306
Neuroscience. 2015 Aug 6;300:63-74
pubmed: 25943480
Exp Brain Res. 2015 Aug;233(8):2335-46
pubmed: 26019008
J Anxiety Disord. 2015 Aug;34:33-42
pubmed: 26114901
Biol Psychiatry. 2015 Dec 15;78(12):871-9
pubmed: 26115790
Neuropsychopharmacology. 2016 Jan;41(1):320-34
pubmed: 26294108
Cogn Emot. 2016 Dec;30(8):1521-1528
pubmed: 26309165
Nat Neurosci. 2015 Oct;18(10):1376-85
pubmed: 26404712
Psychopharmacology (Berl). 2016 Apr;233(7):1135-46
pubmed: 26740318
Behav Brain Res. 2016 Apr 15;303:228-37
pubmed: 26821287
J Neurochem. 1989 May;52(5):1655-8
pubmed: 2709017
J Neurosci Res. 2017 Jan 2;95(1-2):75-82
pubmed: 27870416
Learn Mem. 2016 Nov 15;23(12):689-698
pubmed: 27918273
Biol Psychiatry. 2018 May 15;83(10):895-907
pubmed: 29338843
Behav Brain Res. 2018 Jul 16;347:332-338
pubmed: 29580893
Front Psychiatry. 2018 May 15;9:196
pubmed: 29867615
Front Psychiatry. 2018 Oct 04;9:477
pubmed: 30337890
Front Behav Neurosci. 2018 Oct 31;12:247
pubmed: 30429779
Behaviour. 1977;62(1-2):190-208
pubmed: 562159
Brain Res. 1983 Nov 21;279(1-2):159-70
pubmed: 6640335
J Neurosci. 1994 May;14(5 Pt 1):2531-44
pubmed: 8182426
Psychoneuroendocrinology. 1997 Aug;22(6):443-53
pubmed: 9364622
Am J Psychiatry. 1998 Mar;155(3):344-9
pubmed: 9501743
Biol Psychiatry. 1999 Jan 1;45(1):26-31
pubmed: 9894572
J Neuroendocrinol. 1999 Jan;11(1):11-7
pubmed: 9918224

Auteurs

Lauren E Chaby (LE)

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, United States.
Research Service, John D. Dingell VA Medical Center, Detroit, MI, United States.

Klevis Karavidha (K)

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, United States.

Michael J Lisieski (MJ)

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, United States.

Shane A Perrine (SA)

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, United States.
Research Service, John D. Dingell VA Medical Center, Detroit, MI, United States.

Israel Liberzon (I)

Department of Psychiatry, VA Medical Center, Ann Arbor, MI, United States.
Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States.

Classifications MeSH